Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 50 mg / 1000 mg, 50 mg / 850 mg
Send MessageVildagliptin & Metformin Tablets are a synergistic fixed-dose combination developed for effective control of type 2 diabetes mellitus. This formulation integrates Vildagliptin, a selective DPP-4 inhibitor that enhances endogenous incretin hormone activity, with Metformin, a biguanide that lowers hepatic glucose output and improves insulin sensitivity.
The combination works through complementary pathways—Vildagliptin promotes glucose-dependent insulin secretion and reduces glucagon release, while Metformin addresses insulin resistance and excessive hepatic glucose production. Together, they provide a comprehensive approach to glycemic regulation, targeting both pancreatic function and metabolic efficiency.
Genliva Wellness LLP, Himatnagar, India, is a trusted vildagliptin metformin tablet manufacturer India, offering high-quality combination antidiabetic formulations for domestic supply, export markets, and third-party pharmaceutical manufacturing services.
Vildagliptin & Metformin Tablets are modern oral antidiabetic formulations developed to improve pancreatic responsiveness and optimize glucose metabolism in type 2 diabetes patients. The combination works by increasing active incretin levels while simultaneously reducing excess glucose formation in the liver.
These tablets are widely prescribed for adults with type 2 diabetes who require multi-mechanism glucose management beyond monotherapy. They are especially useful in patients with fluctuating post-meal sugar levels and inadequate metabolic control.
Vildagliptin & Metformin Tablets provide complementary glucose-lowering activity with improved metabolic efficiency and better day-to-day glycemic consistency.
